title: Type 1 Brugada pattern exacerbation and 1:1 atrioventricular conduction induced by vernakalant.
authors: 1st Department of Cardiology, Athens Red Cross Hospital, Athens, Greece. Electronic address: theodoroszografos@gmail.com.
authors: Theodoros A
authors: TA
authors: Zografos
authors: 1st Department of Cardiology, Athens Red Cross Hospital, Athens, Greece.
authors: Spiros P
authors: SP
authors: Kourouklis
authors: 1st Department of Cardiology, Athens Red Cross Hospital, Athens, Greece.
authors: Apostolos
authors: A
authors: Katsivas
mesh_terms: D000840:Anisoles / Q000008:administration & dosage*; D053840:Brugada Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D002036:Bundle of His / Q000187:drug effects* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D004562:Electrocardiography; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D011759:Pyrrolidines / Q000008:administration & dosage*
chemical_list: D000840:Anisoles; D011759:Pyrrolidines; C524581:vernakalant
keywords: Atrial fibrillation; Brugada syndrome; Vernakalant